Silver Spur Therapeutics
June 24, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Platform for Therapeutics
Silver Spur Therapeutics is a preclinical-stage therapeutics company spun out from the Chung Lab at the University of Southern California, focused on developing renal-targeted RNA therapies for Autosomal Dominant Polycystic Kidney Disease (ADPKD) using its proprietary nanoparticle platform for safe, highly selective kidney delivery.
Dr. Eun Ji Chung, Associate Professor of Biomedical Engineering at USC, Founding Director of the Transformative Center for Nanomedicine and Drug Delivery, and co-founder of Silver Spur Therapeutics, is the leader of this innovation; she is a 2025 AIMBE Fellow, 2023 BMES Fellow, NIH Director’s New Innovator Award recipient, and holder of major grants from NIH, DoD, and AHA, with over 80 high-impact publications in nanomedicine and kidney diseases.
Company HQ City:
Palos Verdes Penins
Company HQ State:
CA
Company HQ Country:
United States
Year Founded:
2024
CEO
Laura Bae
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}